Bank of New York Mellon
MANE

Bank of New York Mellon’s Veradermics Inc MANE Stock Holding History

Bank of New York Mellon’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.6M Buy
346,585
+342,917
+9,349% +$32.1M 0.01% 1170
2026
Q1 		$232K Buy
+3,668
New +$185K ﹤0.01% 3950

Other funds holding MANE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return

Bank of New York Mellon's MANE Position: Q2 2026 in Review

Bank of New York Mellon increased its Veradermics Inc (MANE) stake by 9,349% in Q2 2026, buying an estimated $32.1M and bringing the position to 346,585 shares worth $42.6M. The position accounts for 0.01% of the portfolio, ranked #1170.

Bank of New York Mellon first reported a position in MANE in Q1 2026 and has held it in 2 quarters since. 56 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Bank of New York Mellon held 346,585 shares of Veradermics Inc worth $42.6M as of Q2 2026.
  • Bank of New York Mellon bought 342,917 Veradermics Inc shares in Q2 2026, an estimated $32.1M.
  • Veradermics Inc made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1170 holding.
  • Bank of New York Mellon first reported a position in Veradermics Inc in Q1 2026 and has held it in 2 quarters since.
  • 56 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.